TheStreet's Jim Cramer thinks Allergan (AGN) CEO Brent Saunders has put together a world class company. 'I think Allergan has been lumped in with a Valeant Pharmaceuticals (VRX) , Perrigo (PRGO) and Endo Pharmaceuticals (ENDP) and lumped in with all of the generics and I think that's just unfair,' Cramer said. Allergan reports quarterly results on Tuesday before the markets open. The stock is a holding of Cramer's charitable trust, Action Alerts PLUS.
More from Video
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.